Mechanisms and therapeutic applications of immune stimulatory CpG DNA

Citation
Am. Krieg et al., Mechanisms and therapeutic applications of immune stimulatory CpG DNA, PHARM THERA, 84(2), 1999, pp. 113-120
Citations number
64
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGY & THERAPEUTICS
ISSN journal
01637258 → ACNP
Volume
84
Issue
2
Year of publication
1999
Pages
113 - 120
Database
ISI
SICI code
0163-7258(199911)84:2<113:MATAOI>2.0.ZU;2-3
Abstract
Aside from its function as the "blueprint of life" that encodes genetic inf ormation, DNA can have direct immune activities. The immune system has evol ved a defense mechanism that is able to distinguish microbial DNA from our own because of differences in the frequency and methylation of CpG dinucleo tides in particular base contexts. Within minutes of detecting such "GpG-S DNA," cells of the innate immune system become activated and produce cytoki nes that promote the generation of antigen specific T- helper-1-like immune responses. Animal studies indicate therapeutic utility for CpG-S DNA as a vaccine adjuvant and for the immunotherapy of cancer and infectious and all ergic diseases. Published by Elsevier Science Inc.